Moderna Stock Surges After Covid Vaccine Sales Obliterate ExpectationsInvestors Business Daily • 08/03/22
Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shotsCNBC • 08/03/22
Moderna's stock rises 3% after beating earnings expectations in the second quarterMarket Watch • 08/03/22
Moderna Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAccesswire • 08/03/22
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future'Market Watch • 07/29/22
LA County dodges face mask mandate as community transmission rates stabilize, and government orders 66 million doses of Moderna's pending boosterMarket Watch • 07/29/22
U.S. to pay Moderna $1.7 billion for 66 million doses of a new COVID-19 vaccine boosterMarket Watch • 07/29/22
Moderna Announces New Supply Contract With The U.S. Government For An Initial 66 Million Doses Of A Moderna Bivalent Covid-19 Booster Vaccine With Options For U.S. Government To Purchase Up To An Additional 234 Million DosesAccesswire • 07/29/22
Is Moderna Stock A Sell On Projections For Its First Quarterly Decline Since 2020?Investors Business Daily • 07/26/22
EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European UnionAccesswire • 07/22/22